Skip to main content
TipRanks
Go Ultimate75% OFF

Paradigm Biopharmaceuticals (PBIGF) Revenue

17 Followers

Paradigm Biopharmaceuticals Revenue

Paradigm Biopharmaceuticals had a revenue of 55.00K in the quarter ending Jun 30, 2026, with 118.69%. This bring the company's revenue in the last twelve months to 80.15K, Increased 32.33%. In the fiscal year ending Jun 30, 2026, Paradigm Biopharmaceuticals had annual revenue of 80.15K with 53.78% growth.

Revenue (ttm)
80.15K
Revenue Growth
64.49%
P/S Ratio
1311.55
Revenue/Employee
$6,679
Employees
12
Market Cap
$105.12M

Revenue Chart

Paradigm Biopharmaceuticals Revenue - Annual

0500K1M1.5M2M2.5M3M3.5M1.82M2.68M2.98M20.55K79.22K46.76K65.80K52.12K80.15K2017201820192020202120222023202420252026
Revenue History
Download to Excel
PBIGF revenue history
Fiscal End DateRevenueChangeGrowth
Jun 30, 202680.15K28.03K53.78%
Jun 30, 202552.12K-13.68K-20.79%
Jun 30, 202465.80K19.04K40.72%
Jun 30, 202346.76K-32.46K-40.98%
Jun 30, 202279.22K58.67K285.52%
Jun 30, 202120.55K20.55K―
Jun 30, 20200.00-2.98M-100.00%
Jun 30, 20192.98M301.00K11.22%
Jun 30, 20182.68M860.00K47.17%
Jun 30, 20171.82M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
PBIGF80.15K
AU:ATX0.00
AU:ACW0.00
AU:DXB4.35M
AU:BOT34.51M
AU:RCE0.00